{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:35:20Z","timestamp":1758040520875,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.amjmed.2008.01.025","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T03:13:12Z","timestamp":1209870792000},"page":"360-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Psoriasis and Vascular Disease: An Unsolved Mystery"],"prefix":"10.1016","volume":"121","author":[{"given":"Michael L.","family":"Shelling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Federman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdjan","family":"Prodanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Kirsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2008.01.025_bib2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Schon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","article-title":"The natural history of psoriasis in 5,600 patients","volume":"148","author":"Farber","year":"1974","journal-title":"Dermatologica"},{"key":"10.1016\/j.amjmed.2008.01.025_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2133.1992.tb00116.x","article-title":"Family history, smoking habits, alcohol consumption and risk of psoriasis","volume":"127","author":"Naldi","year":"1992","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2008.01.025_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archderm.1974.01630020023005","article-title":"Natural history of psoriasis in 61 twin pairs","volume":"109","author":"Farber","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2008.01.025_bib7","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis\u2014recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1440-0960.2006.00262.x","article-title":"Immunopathogenesis of psoriasis","volume":"47","author":"Lee","year":"2006","journal-title":"Australas J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.amjmed.2008.01.025_bib9","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2008.01.025_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2008.01.025_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the cytokine code in psoriasis","volume":"13","author":"Nickoloff","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis","volume":"356","author":"Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaad.2006.09.017","article-title":"The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study","volume":"56","author":"Shapiro","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-8981(00)00358-2","article-title":"Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease","volume":"303","author":"Rocha-Pereira","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjmed.2008.01.025_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.amjmed.2008.01.025_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2008.01.025_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(03)00082-2","article-title":"Plasma homocysteine and its relationship with atherothrombotic markers in psoriatic patients","volume":"332","author":"Kural","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjmed.2008.01.025_bib21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.158.12.1301","article-title":"Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment","volume":"158","author":"Stein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000096748","article-title":"Homocysteine and large arteries","volume":"44","author":"Van Guldener","year":"2007","journal-title":"Adv Cardiol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","article-title":"Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/039463200601900405","article-title":"VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study","volume":"19","author":"Simonetti","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib25","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0022-202X.2005.23681.x","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study","volume":"125","author":"Naldi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib27","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archderm.141.12.1580","article-title":"Relationship between smoking and the clinical severity of psoriasis","volume":"141","author":"Fortes","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjmed.2007.06.020","article-title":"Smoking and the risk of psoriasis in women: Nurses' Health Study II","volume":"120","author":"Setty","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000090652","article-title":"An Italian study of psoriasis and depression","volume":"212","author":"Esposito","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2008.01.025_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-0960.2004.00078.x","article-title":"Psychiatric morbidity in psoriasis: a review","volume":"45","author":"Russo","year":"2004","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The psychosocial burden of psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000102029","article-title":"Role of depression in quality of life for patients with psoriasis","volume":"215","author":"Schmitt","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2008.01.025_bib33","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.166.18.2035","article-title":"Time course of depression and outcome of myocardial infarction","volume":"166","author":"Parashar","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","article-title":"Depression following myocardial infarction","volume":"270","author":"Frasure-Smith","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2008.01.025_bib35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","article-title":"Depression and 18-month prognosis after myocardial infarction","volume":"91","author":"Frasure-Smith","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2008.01.025_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","article-title":"Psoriasis and occlusive vascular disease","volume":"99","author":"McDonald","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000249365","article-title":"Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes","volume":"172","author":"Lindegard","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.amjmed.2008.01.025_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09546630500335977","article-title":"The comorbid state of psoriasis patients in a university dermatology practice","volume":"16","author":"Pearce","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2008.01.025_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","article-title":"Psoriasis: a possible risk factor for development of coronary artery calcification","volume":"156","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2008.01.025_bib41","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib42","first-page":"II2","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2008.01.025_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.01.025_bib44","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.autrev.2005.08.008","article-title":"Premature atherosclerotic disease in systemic lupus erythematosus\u2014role of inflammatory mechanisms","volume":"5","author":"Rhew","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.amjmed.2008.01.025_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1468-3083.2006.01773.x","article-title":"Comorbidities in psoriasis","volume":"20","author":"Christophers","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2008.01.025_bib48","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib49","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2008.01.025_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jbspin.2006.01.014","article-title":"Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion","volume":"73","author":"Pham","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.amjmed.2008.01.025_bib51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib52","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib53","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","article-title":"Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy","volume":"54","author":"Markham","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.2005.06648.x","article-title":"Cytokine profiles during infliximab monotherapy in psoriatic arthritis","volume":"153","author":"Mastroianni","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2008.01.025_bib55","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.jaad.2005.04.031","article-title":"A clinician's paradigm for the treatment of psoriasis","volume":"53","author":"Lebwohl","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:46:54Z","timestamp":1757580414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934308000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0002934308000648"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.01.025","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis and Vascular Disease: An Unsolved Mystery","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}